|Mr. Timothy P. Herbert||CEO, Pres & Director||1.27M||N/A||1963|
|Mr. Richard J. Buchholz||Chief Financial Officer||651.47k||3.28M||1968|
|Mr. Philip J. Ebeling||Chief Operating Officer||645.1k||N/A||1971|
|Mr. Bryan K. Phillips||Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.||639.9k||N/A||1971|
|Mr. Randall A. Ban||Chief Commercial Officer||609.72k||7.78M||1965|
|Mr. John C. Rondoni||Chief Technology Officer||N/A||N/A||N/A|
|Mr. Martin A. Abrams||VP of Marketing & Customer Experience||N/A||N/A||N/A|
|Mr. Steven L. Jandrich||VP of HR||N/A||N/A||1967|
|Mr. Ivan Lubogo||Sr. VP of U.S. Sales||N/A||N/A||N/A|
|Mr. Andreas Henke||Sr. VP & MD of Europe||N/A||N/A||N/A|
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc.’s ISS governance QualityScore as of 1 February 2023 is 8. The pillar scores are Audit: 8; Board: 7; Shareholder rights: 8; Compensation: 9.